Hyperfine plans to use the data to support its first expanded indication submission for the Swoop system since FDA clearance.

By Nancy Lapid Sept 15 (Reuters) - Hello Health Rounds readers! Today we highlight a potentially game-changing experimental contrast agent for MRI exams that may enable detection of lung cancer when ...

A multi-institutional research team led by Georgia State University Regents' Professor Emerita of Biochemistry and ...

The imaging agent could potentially help doctors characterize a malignancy's aggression and identify lesions with a higher ...

A breakthrough experimental contrast agent for MRI exams may enable the early detection of lung cancer, according to researchers. The agent, named hProCA32.Collagen2, identified small tumors and ...

Completion of enrollment in study to support anticipated indication expansion for use of the Swoop® system with contrast agents.

Simulations reveal details about the magnetic interactions between gadolinium contrast agents used in MRI scans and their environment. You can keep your best guesses. Engineers at Rice University's ...

Scientists at the University of Birmingham have developed a new class of MRI contrast agents: improving their stability to create a significant advancement in medical imaging technology. Metallo ...

BERLIN--(BUSINESS WIRE)--Bayer, a global leader in radiology, today announced positive topline results of the pivotal Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane, an ...